Olympic gold medalist Caster Semenya has publicly criticized the International Olympic Committee (IOC) for its newly announced policy aimed at ensuring fairness in women's events at the Olympics. The IOC's policy, which will be implemented starting with the LA28 Olympic Games, requires genetic testing to verify the biological sex of competitors in women's events. Eligibility for these events will be limited to biological females, determined by a one-time SRY gene screening, according to the IOC [1].
Semenya, who has disorders of sex development (DSD) and higher-than-typical female testosterone levels, has previously launched legal challenges to compete in the women's category. She expressed disappointment in IOC President Kirsty Coventry, stating, "Personally, for her as a leader, she’s an African, I’m sure she understands how, you know, we as Africans, we are coming from, as a global South, you know, you cannot control genetics" [1]. Semenya further criticized the policy's scientific basis, demanding transparency about who made the decisions and accusing the IOC of merely "ticking a box" in consultations [1].
The IOC claims the policy is "evidence‑based and expert‑informed," developed after consulting a panel of experts to protect fairness, safety, and integrity in the female category. The organization emphasized its commitment to equality, Olympic values, and the visibility of female athletes, stating that the policy ensures equal opportunities for women in finals, podiums, and championships [1].
Semenya, who won Olympic gold medals in the 800-meter race at the 2012 and 2016 Games, is currently banned from competing in certain international meets, including the Olympics and world championships, due to her refusal to take medication to reduce her hormone levels [1].
CONCLUSION
The IOC's new policy introduces genetic testing to determine eligibility for women's Olympic events, sparking strong criticism from Caster Semenya and raising questions about fairness and scientific transparency. While the IOC asserts the policy is designed to protect integrity and equality in sport, the controversy highlights ongoing debates about inclusion and the impact on athletes with DSD. Market sentiment is negative, reflecting concerns about the policy's implications for athlete participation and public perception.